Key Events This Week
22 Jun: New 52-week high (Rs.153)
22 Jun: All-time high reached (Rs.153)
24 Jun: Golden Cross formation signalling bullish breakout
25 Jun: Week closes at Rs.126.05 (-1.18%)
Aug 28, 03:30 PM
BSE+NSE Vol: 34.08 k

Lotus Eye Hospital & Institute Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 05 June 2026, reflecting a shift from a previous 'Strong Sell' stance. However, the analysis and financial metrics discussed here represent the stock's current position as of 25 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Lotus Eye Hospital & Institute Ltd has seen a significant shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. Despite this, the stock’s returns over various time frames have been mixed, with some periods outperforming the Sensex while others lag behind. This article analyses the recent valuation changes, compares key financial metrics with peers, and assesses the implications for investors.
Read full news article
Lotus Eye Hospital & Institute Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 5 June 2026. However, the analysis below reflects the stock's current position as of 14 August 2026, incorporating the latest financial metrics, returns, and market data to provide investors with an up-to-date perspective.
Read full news article
Lotus Eye Hospital & Institute Ltd has experienced a significant change in its valuation parameters, shifting from a risky to an expensive classification. Despite a recent uptick in share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to peers and historical averages raise questions about its current price attractiveness for investors.
Read full news article
Lotus Eye Hospital & Institute Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 August 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Lotus Eye Hospital & Institute Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Lotus Eye Hospital & Institute Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Lotus Eye Hospital & Institute Ltd is rated Sell by MarketsMOJO. This rating was last updated on 05 Jun 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 30 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleLotus Eye Hospital and Institute Limiteds Eye Hospital and Institute Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Lotus Eye Hospital and Institute Limited has informed the Exchange regarding Board meeting held on November 14, 2019.
Lotus Eye Hospital and Institute Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2019. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
No Upcoming Board Meetings
Lotus Eye Hospital & Institute Ltd has declared 5% dividend, ex-date: 18 Sep 23
No Splits history available
No Bonus history available
No Rights history available